InvestorsHub Logo

Lorcan458

12/20/17 7:10 PM

#2413 RE: jfk #2412

We may have some news about MS entering phase 1. They had a press release with some relatively famous reporter who took the MS treatment and there is video of his good results. Since Brainstorm is using the bodies own stem cells, and their proprietary incubation process allows customization of what the stem cells will produce (neurotrophic factors, etc.), it may be that the results of ALS testing will give more confidence on MS and vice-versa. If they end up having basically conquered all central nervous system diseases, this will be a huge win for humanity and for stockholders.

Of course, things could go the other way as well, but I haven't seen a single negative response from patients in any of the data I can find. Do your own research and let us know if you find anything (positive or negative). I'm more of a tech geek than medical guru, but from what I can tell by the graphs and charts from the other phases of testing, I'm building my share count.

TetonBill

12/21/17 2:30 PM

#2414 RE: jfk #2412

Agree, that's a disappointingly long time before P3 results are announced. But I thought, in the meantime, we were waiting on two possibly important events: 1. approval for treatment of patients in Canada, and 2. approval for treatment of patients in Israel. Is this correct? If so, and if approval is received from either country, I think that announcement could goose the stock price - which has taken an awful tumble so far today.